SynthesisBMC infectious diseases2025
Prevalence of methicillin-resistant coagulase-negative staphylococci in Africa: a systematic review and meta-analysis.
Synthesis in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Distribution and characteristics of methicillin-resistant staphylococci from non-clinical environments in southern Vietnam.BMC microbiology · 2026Article
- Coagulase-Negative Staphylococci (CoNS): An Emerging Threat, Antimicrobial Resistance, and Health Concern.International journal of microbiology · 2026Review
- Culture-Based Wastewater Surveillance for the Detection and Monitoring of Antimicrobial Resistance in Staphylococcal Species.Veterinary sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Coagulase-negative staphylococci (CoNS) represent a diverse group of opportunistic pathogens associated with human and animal infections. The burden of infectious diseases attributed to antibiotic-resistant CoNS, particularly methicillin-resistant CoNS (MR-CoNS), is a global public health concern. However, there is limited data on the epidemiology of MR-CoNS in Africa. This systematic review provides insights on MR-CoNS from human and non-human sources in Africa, the methicillin-resistance gene determinants and the associated mobile genetic elements. The review retrieved articles from four electronic databases: PubMed, Scopus, Web of Science, and Google Scholar, using specific keywords. This study was carried out until 20 November 2024. Articles were screened and data was extracted and analyzed following the PRISMA guidelines. The meta-analysis used the binary random effects model with a 95% confidence interval. Overall, 65 articles from 16 African countries were included in the study. The pooled prevalence rates for CoNS and MR-CoNS in Africa were 27% and 36%, respectively. The review identified 36 species of CoNS from human and non-human sources. In addition, 20 (31%) studies each reported CoNS and MR-CoNS from human and animal infections. The most prevalent species of MR-CoNS included Staphylococcus epidermidis, Staphylococcus haemolyticus, and Mammaliicoccus sciuri. The African MR-CoNS harboured different staphylococcal chromosome cassette mec (SCCmec) elements (types I, II, III, IV, V, VI, VIII, and a SCCmec-mecC (hybrid), and the most common SCCmec element was the SCCmec type IV. The findings highlight the paucity of data on the epidemiology of MR-CoNS in Africa. The identification of MR-CoNS from human and animal infections indicates the need for a detailed characterization using molecular methods. This strategy will provide data to healthcare practitioners and policymakers to develop effective measures to combat antimicrobial resistance in Africa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.